CAM
Cormorant Asset Management’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.88M | Hold |
254,161
| – | – | 0.21% | 39 |
|
|
2025
Q1 | $1.69M | Hold |
254,161
| – | – | 0.13% | 41 |
|
|
2024
Q4 | $2.8M | Sell |
254,161
-173,002
| -41% | -$1.91M | 0.15% | 44 |
|
|
2024
Q3 | $5.25M | Hold |
427,163
| – | – | 0.28% | 39 |
|
|
2024
Q2 | $5.77M | Hold |
427,163
| – | – | 0.33% | 41 |
|
|
2024
Q1 | $5.77M | Sell |
427,163
-660,644
| -61% | -$8.92M | 0.25% | 51 |
|
|
2023
Q4 | $5.72M | Hold |
1,087,807
| – | – | 0.27% | 39 |
|
|
2023
Q3 | $4.29M | Hold |
1,087,807
| – | – | 0.25% | 40 |
|
|
2023
Q2 | $11.6M | Hold |
1,087,807
| – | – | 0.65% | 34 |
|
|
2023
Q1 | $9.06M | Hold |
1,087,807
| – | – | 0.6% | 40 |
|
|
2022
Q4 | $10M | Hold |
1,087,807
| – | – | 0.67% | 39 |
|
|
2022
Q3 | $14M | Hold |
1,087,807
| – | – | 0.98% | 36 |
|
|
2022
Q2 | $14.4M | Hold |
1,087,807
| – | – | 1.09% | 30 |
|
|
2022
Q1 | $22.9M | Sell |
1,087,807
-94,555
| -8% | -$1.99M | 1.76% | 16 |
|
|
2021
Q4 | $28.4M | Sell |
1,182,362
-95,914
| -8% | -$2.3M | 1.69% | 19 |
|
|
2021
Q3 | $32.5M | Hold |
1,278,276
| – | – | 1.32% | 23 |
|
|
2021
Q2 | $43M | Sell |
1,278,276
-159,531
| -11% | -$5.37M | 1.46% | 20 |
|
|
2021
Q1 | $55.8M | Hold |
1,437,807
| – | – | 1.24% | 16 |
|
|
2020
Q4 | $89M | Sell |
1,437,807
-100,000
| -7% | -$6.19M | 2.12% | 8 |
|
|
2020
Q3 | $51.5M | Sell |
1,537,807
-163,485
| -10% | -$5.48M | 1.98% | 14 |
|
|
2020
Q2 | $40.5M | Sell |
1,701,292
-8,473
| -0.5% | -$202K | 1.55% | 21 |
|
|
2020
Q1 | $39.2M | Sell |
1,709,765
-78,878
| -4% | -$1.81M | 1.82% | 14 |
|
|
2019
Q4 | $50.7M | Buy |
1,788,643
+249
| +0% | +$7.05K | 2.02% | 15 |
|
|
2019
Q3 | $38.4M | Sell |
1,788,394
-81,286
| -4% | -$1.75M | 2.34% | 9 |
|
|
2019
Q2 | $54.5M | Buy |
+1,869,680
| New | +$54.5M | 3.13% | 7 |
|